Sun Pharma's Dilip Shanghvi Aims To Raise R&D Spend To $1 Billion — NDTV Profit Exclusive

Sun Pharmaceuticals Industries Ltd. Managing Director Dilip Shanghvi aspires to increase the company's research and development spend to a billion dollars in the next three to five years.The company aims to go from the current 7% R&D revenue level to 9% in terms of overall R&D spend, he said at the Vriddhi 2024 conference by the Indian Drug Manufacturers’ Association in Pune on Feb. 24. "This will help bring newer and innovative prod...